{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:18:19Z","timestamp":1789471099801,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200186"],"award-info":[{"award-number":["82200186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["SL2023A04J01861"],"award-info":[{"award-number":["SL2023A04J01861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.intimp.2025.114665","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T14:40:23Z","timestamp":1744987223000},"page":"114665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CD40 promotes AML survival via non-canonical NF-\u03baB signaling and aberrant lipid metabolism"],"prefix":"10.1016","volume":"156","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2025.114665_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000536152","article-title":"Pathophysiology of acute myeloid leukemia","volume":"147","author":"Wachter","year":"2024","journal-title":"Acta Haematol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.JAA.0000995680.52352.b5","article-title":"Acute myeloid leukemia: current understanding and management","volume":"37","author":"Becker","year":"2024","journal-title":"Jaapa"},{"issue":"4","key":"10.1016\/j.intimp.2025.114665_bb0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bjh.15032","article-title":"Advances in targeted therapy for acute myeloid leukaemia","volume":"180","author":"Kayser","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114665_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"issue":"12","key":"10.1016\/j.intimp.2025.114665_bb0025","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114665_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/asheducation-2011.1.43","article-title":"Novel approaches to the treatment of acute myeloid leukemia","volume":"2011","author":"Roboz","year":"2011","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.intimp.2025.114665_bb0035","series-title":"Cancer Vaccines","first-page":"165","article-title":"The use of anti-CD40 mAb in Cancer","author":"Remer","year":"2017"},{"issue":"7","key":"10.1016\/j.intimp.2025.114665_bb0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41568-024-00699-2","article-title":"Exploiting temporal aspects of cancer immunotherapy","volume":"24","author":"Zemek","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"26","key":"10.1016\/j.intimp.2025.114665_bb0045","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.intimp.2025.114665_bb0050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114665_bb0055","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.celrep.2016.05.058","article-title":"CD40 stimulation obviates innate sensors and drives T cell immunity in Cancer","volume":"15","author":"Byrne","year":"2016","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.intimp.2025.114665_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","article-title":"Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape","volume":"48","author":"Wellenstein","year":"2018","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.intimp.2025.114665_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314937","article-title":"Genetic heterogeneity, tumor microenvironment and immunotherapy in triple-negative breast Cancer","volume":"23","author":"Kudelova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2025.114665_bb0070","first-page":"515","article-title":"Role for CD40\u2013CD40 ligand interactions in the immune response to solid tumours","volume":"37","author":"Alexandroff","year":"2000"},{"issue":"9","key":"10.1016\/j.intimp.2025.114665_bb0075","first-page":"4467","article-title":"CD40 expression in human esophageal squamous cell carcinoma is associated with tumor progression and lymph node metastasis","volume":"36","author":"Matsumura","year":"2016"},{"issue":"6","key":"10.1016\/j.intimp.2025.114665_bb0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","article-title":"The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death","volume":"76","author":"Smith","year":"1994","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2025.114665_bb0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.coph.2004.02.008","article-title":"The role of the CD40 pathway in the pathogenesis and treatment of cancer","volume":"4","author":"Eliopoulos","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114665_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578069","article-title":"A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-\u03baB and notch inflammatory signaling in the BTBR mouse model of autism","volume":"377","author":"Alomar","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114665_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087475","article-title":"Upregulation of inflammatory mediators in peripheral blood CD40(+) cells in children with autism Spectrum disorder","volume":"24","author":"Aldossari","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.114665_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061511","article-title":"DAPTA, a C-C chemokine receptor 5 (CCR5), leads to the downregulation of notch\/NF-\u03baB signaling and Proinflammatory mediators in CD40(+) cells in experimental autoimmune encephalomyelitis model in SJL\/J mice","volume":"11","author":"Alghibiwi","year":"2023","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.intimp.2025.114665_bb0105","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1158\/0008-5472.CAN-07-0696","article-title":"Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors","volume":"67","author":"Stavenhagen","year":"2007","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.114665_bb0110","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1158\/1078-0432.CCR-06-1893","article-title":"Prospect of targeting the CD40 pathway for cancer therapy","volume":"13","author":"Vonderheide","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.114665_bb0115","article-title":"Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients","volume":"8","author":"Machiels","year":"2020","journal-title":"J. Immuno. Therapy Cancer"},{"key":"10.1016\/j.intimp.2025.114665_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-med-062518-045435","article-title":"CD40 agonist antibodies in Cancer immunotherapy","volume":"71","author":"Vonderheide","year":"2020","journal-title":"Annu. Rev. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114665_bb0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14712598.2024.2357714","article-title":"Next-generation CD40 agonists for cancer immunotherapy","volume":"24","author":"Andersson","year":"2024","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.intimp.2025.114665_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-8722-7-44","article-title":"A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors","volume":"7","author":"de Vos","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"15_suppl","key":"10.1016\/j.intimp.2025.114665_bb0135","article-title":"A phase I study of CD40 agonist ABBV-927 plus OX40 agonist ABBV-368 with or without the PD-1 inhibitor budigalimab in patients with advanced solid tumors","volume":"38","author":"Powderly","year":"2020"},{"issue":"7","key":"10.1016\/j.intimp.2025.114665_bb0140","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2309439","article-title":"Inhibition of CD40L with Frexalimab in multiple sclerosis","volume":"390","author":"Vermersch","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114665_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112897","article-title":"ROCK2 increases drug resistance in acute myeloid leukemia via metabolic reprogramming and MAPK\/PI3K\/AKT signaling","volume":"140","author":"Yan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114665_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156672","article-title":"IL-33-dependent NF-\u03baB activation inhibits apoptosis and drives chemoresistance in acute myeloid leukemia","volume":"180","author":"Yan","year":"2024","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.intimp.2025.114665_bb0155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114665_bb0160","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nprot.2011.366","article-title":"Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling","volume":"6","author":"Sellick","year":"2011","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.intimp.2025.114665_bb0165","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nprot.2012.024","article-title":"A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue","volume":"7","author":"Yuan","year":"2012","journal-title":"Nat. Protoc."},{"issue":"21","key":"10.1016\/j.intimp.2025.114665_bb0170","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260298","article-title":"GM-CSF-activated human dendritic cells promote type 1 T follicular helper cell polarization in a CD40-dependent manner","volume":"135","author":"Korniotis","year":"2022","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2023022481","article-title":"How I treat refractory and relapsed acute myeloid leukemia","volume":"143","author":"Thol","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2025.114665_bb0180","first-page":"67","article-title":"Agonistic and antagonistic properties of CD40 mAb G28-5 are dependent on binding valency","volume":"44","author":"Ledbetter","year":"1994","journal-title":"Circ. Shock."},{"key":"10.1016\/j.intimp.2025.114665_bb0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12896-016-0237-1","article-title":"Expression, purification and biological characterization of the extracellular domain of CD40 from Pichia pastoris","volume":"16","author":"Zhan","year":"2016","journal-title":"BMC Biotechnol."},{"issue":"20","key":"10.1016\/j.intimp.2025.114665_bb0190","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1093\/emboj\/cdf542","article-title":"CD40 regulates the processing of NF-\u03baB2 p100 to p52","volume":"21","author":"Coope","year":"2002","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.intimp.2025.114665_bb0195","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41418-020-00692-w","article-title":"Regulation of Bcl-XL by non-canonical NF-\u03baB in the context of CD40-induced drug resistance in CLL","volume":"28","author":"Haselager","year":"2021","journal-title":"Cell Death Differ."},{"issue":"47","key":"10.1016\/j.intimp.2025.114665_bb0200","doi-asserted-by":"crossref","first-page":"14664","DOI":"10.1073\/pnas.1520627112","article-title":"Dendritic cells require NIK for CD40-dependent cross-priming of CD8<sup>+<\/sup> T cells","volume":"112","author":"Katakam","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5534","key":"10.1016\/j.intimp.2025.114665_bb0205","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1126\/science.1062677","article-title":"Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway","volume":"293","author":"Senftleben","year":"2001","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.intimp.2025.114665_bb0210","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1093\/emboj\/cdf542","article-title":"CD40 regulates the processing of NF-kappaB2 p100 to p52","volume":"21","author":"Coope","year":"2002","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0215","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0220","doi-asserted-by":"crossref","first-page":"21809","DOI":"10.1038\/s41598-023-48970-0","article-title":"Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy","volume":"13","author":"Bolkun","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0225","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00005-022-00665-6","article-title":"Application of metabolomics in childhood leukemia diagnostics","volume":"70","author":"Kozio\u0142","year":"2022","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"11","key":"10.1016\/j.intimp.2025.114665_bb0230","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1084\/jem.20060844","article-title":"Triggering CD40 on endothelial cells contributes to tumor growth","volume":"203","author":"Chiodoni","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1476-4598-13-85","article-title":"Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death","volume":"13","author":"Brunekreeft","year":"2014","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2025.114665_bb0240","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3324\/haematol.2016.157206","article-title":"CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis","volume":"102","author":"van Attekum","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2025.114665_bb0245","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.wneu.2019.05.112","article-title":"Expression of CD40 correlates negatively with overall and progression-free survival of low- and high-grade gliomas","volume":"130","author":"Werner","year":"2019","journal-title":"World Neurosurg."},{"issue":"11","key":"10.1016\/j.intimp.2025.114665_bb0250","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0301-472X(02)00921-9","article-title":"CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts","volume":"30","author":"Aldinucci","year":"2002","journal-title":"Exp. Hematol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114665_bb0255","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cncr.21816","article-title":"Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies","volume":"106","author":"Hock","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2025.114665_bb0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuro.2020.10.014","article-title":"Methylmercury chloride exposure aggravates proinflammatory mediators and Notch-1 signaling in CD14+ and CD40+ cells and is associated with imbalance of neuroimmune function in BTBR T+ Itpr3tf\/J mice","volume":"82","author":"Ahmad","year":"2021","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.intimp.2025.114665_bb0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopha.2018.12.060","article-title":"Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis","volume":"111","author":"Alzahrani","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2025.114665_bb0270","first-page":"2188","article-title":"Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cells","volume":"19","author":"Feng","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40170-021-00253-w","article-title":"Mitochondrial metabolism as a target for acute myeloid leukemia treatment","volume":"9","author":"Panina","year":"2021","journal-title":"Cancer & Metabolism"},{"issue":"10","key":"10.1016\/j.intimp.2025.114665_bb0280","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cells9102308","article-title":"Cancer metabolism: phenotype, signaling and therapeutic targets","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"issue":"25","key":"10.1016\/j.intimp.2025.114665_bb0285","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.2020008551","article-title":"Very long chain fatty acid metabolism is required in acute myeloid leukemia","volume":"137","author":"Tcheng","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2025.114665_bb0290","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3390\/cells10092287","article-title":"Omega-3 fatty acids DHA and EPA reduce Bortezomib resistance in multiple myeloma cells by promoting glutathione degradation","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.intimp.2025.114665_bb0295","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.114665_bb0305","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114665_bb0310","article-title":"Omega-3 fatty acids and Cancer cell cytotoxicity: implications for multi-targeted Cancer therapy","volume":"5","author":"D'Eliseo","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2025.114665_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2019.103739","article-title":"Anti-tumor mechanism of eicosapentaenoic acid (EPA) on ovarian tumor model by improving the immunomodulatory activity in F344 rats","volume":"65","author":"Bie","year":"2020","journal-title":"J. Funct. Foods"},{"issue":"Supplement 1","key":"10.1016\/j.intimp.2025.114665_bb0320","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/blood-2024-208946","article-title":"Immune checkpoint inhibitors reverse the mesenchymal stromal cell-mediated immunosuppression in acute myeloid leukemia microenvironment","volume":"144","author":"Liu","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.intimp.2025.114665_bb0325","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.114665_bb0330","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41421-024-00767-9","article-title":"NF-\u03baB RelB suppresses the inflammatory gene expression programs of dendritic cells by competing with RelA for binding to target gene promoters","volume":"11","author":"Navarro","year":"2025","journal-title":"Cell Discovery"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:58:33Z","timestamp":1778619513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925006551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":66,"alternative-id":["S1567576925006551"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114665","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD40 promotes AML survival via non-canonical NF-\u03baB signaling and aberrant lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114665"}}